AMP-activated protein kinase activators in diabetic ulcers: from animal studies to Phase II drugs under investigation.
about
Ginkgolide C Suppresses Adipogenesis in 3T3-L1 Adipocytes via the AMPK Signaling Pathway.Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice5-Aminoimidazole-4-carboxamide ribonucleoside-mediated adenosine monophosphate-activated protein kinase activation induces protective innate responses in bacterial endophthalmitis.Effects of the Nrf2 Protein Modulator Salvianolic Acid A Alone or Combined with Metformin on Diabetes-associated Macrovascular and Renal InjuryMetformin accelerates wound healing in type 2 diabetic db/db mice.
P2860
AMP-activated protein kinase activators in diabetic ulcers: from animal studies to Phase II drugs under investigation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
AMP-activated protein kinase a ...... II drugs under investigation.
@en
type
label
AMP-activated protein kinase a ...... II drugs under investigation.
@en
prefLabel
AMP-activated protein kinase a ...... II drugs under investigation.
@en
P2093
P2860
P1476
AMP-activated protein kinase a ...... II drugs under investigation.
@en
P2093
Han-Min Chen
Jiun-Tsai Lin
Yao-Jen Liang
P2860
P304
P356
10.1517/13543784.2014.922951
P407
P577
2014-05-26T00:00:00Z